RxDoctor Payments Data

Barry Coller

Hematology · New York, NYNPI 1043227416

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $7,926,291 of the $7,929,521 with a category attached, or 100.0%. Instrumentation Laboratory Company accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $1,400,974 and has fallen 95.5% since, to $62,787 in 2025. Among hematology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,929,521in general payments, 2019–2025

Across 23 payments — averaging $344,762 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Instrumentation Laboratory Company$7.9M
  • Chugai Pharmaceutical Co., Ltd.$3K

What the payments were for

  • Royalty or licence$7,926,291100%
  • Consulting fees$3,2300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,929,521 in reported general payments places this provider in the 95th percentile of 157 hematology providers in New York.

See all hematology providers in New York

Other hematology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →